Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Arch Dermatol Res. 2016 Oct 20;309(1):11–19. doi: 10.1007/s00403-016-1698-8

Fig. 4. MicroRNA-214 is mainly expressed in CD164+CD4+ T cells from Sézary syndrome patients.

Fig. 4

CD4+T cells from B2 patients (Fig. 4a, n=17), and from B1-B0 patients (Fig. 4b, n=8) were assessed for the expression of miR-214 by qRT-PCR. The expression of miR-214 was subsequently assessed in sorted CD164+/CD164−CD4+ T cells from B2 patients (Fig. 4c, n=15). Error bars represent mean +/− SEM. P values: **<0.005;